This site is intended for healthcare professionals practicing in the US.
©2022 AstraZeneca. All rights reserved.
US-69609
Last Updated 11/22
VIDEO
VIDEO
This video discusses the causes of irreversible organ damage in SLE
VIDEO
VIDEO
This video discusses the type I interferon story in SLE.
VIDEO
VIDEO
This video discusses whether there are differences in Type I interferon expression based on ethnicity
VIDEO
VIDEO
This video discusses the role of type I Interferon in chronic SLE disease
VIDEO
VIDEO
This video discusses type I interferon and potential links to SLE clinical manifestations
VIDEO
VIDEO
The video discusses the interferon gene signature (IFNGS)
VIDEO
The information provided on this site is intended for use by healthcare professionals practicing in the US. The dissemination of this information may be subject to different medical and regulatory requirements in other countries.
This web site is intended to help healthcare professionals practicing in the US and AstraZeneca authorized persons find scientifically balanced, evidence-based information about AstraZeneca drugs, submit a question, ask for field medical follow-up, and explore links to professional and patient support resources.
Are you a healthcare professional practicing in the United States?